רבטול ישראל - עברית - Ministry of Health

רבטול

merck sharp & dohme israel ltd - ribavirin - קפסולות - ribavirin 200 mg - ribavirin - ribavirin - rebetol is indicated for the treatment of chronic hepatitis c and must only be used as part of a combination regimen with peginterferon alfa-2b (adults) or interferon alfa-2b (adults). rebetol monotherapy must not be used. there is no safety or efficacy information on the use of rebetol with other forms of interferon (i.e., not alfa-2b).previously untreated (na?ve) patients rebetol is indicated in adult patients :• in combination with peginterferon alfa-2b or interferon alfa-2b , for the treatment of adult patients with chronic hepatitis c, not previously treated, without liver decompensation, with elevated alanine aminotransferase (alt), who are positive for serum hcv-rna . additionally, rebetol is indicated , in combination with peginterferon alfa-2b, for the treatment of adult patients with chronic hepatitis c ,not previously treated, without liver decompensation, with elevated alanine aminotransferase (alt), who are positive for serum hcv-rna including patients with clinically stable hiv co-infection. pre

אדנוקור ישראל - עברית - Ministry of Health

אדנוקור

sanofi - aventis israel ltd - adenosine - תמיסה להזרקה - adenosine 6 mg / 2 ml - adenosine - adenosine - rapid conversion to a normal sinus rhythm of paroxymal supraventicular tachycardias including those associated with accessory bypass tracts (wolf parkinson-white syndrome).

קוראלאן 7.5 מג ישראל - עברית - Ministry of Health

קוראלאן 7.5 מג

medison pharma ltd - ivabradine as hydrochloride - טבליות מצופות פילם - ivabradine as hydrochloride 7.5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.

קוראלאן 5 מג ישראל - עברית - Ministry of Health

קוראלאן 5 מג

medison pharma ltd - ivabradine as hydrochloride - טבליות מצופות פילם - ivabradine as hydrochloride 5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.

רנקסה 1000 מ"ג ישראל - עברית - Ministry of Health

רנקסה 1000 מ"ג

neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

רנקסה 1000 מ"ג ישראל - עברית - Ministry of Health

רנקסה 1000 מ"ג

neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

רנקסה 500 מ"ג ישראל - עברית - Ministry of Health

רנקסה 500 מ"ג

neopharm ltd - ranolazine 500 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

רנקסה 500 מ"ג ישראל - עברית - Ministry of Health

רנקסה 500 מ"ג

neopharm ltd - ranolazine 500 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

פירזיר 30 מג ישראל - עברית - Ministry of Health

פירזיר 30 מג

takeda israel ltd - icatibant as acetate - תמיסה להזרקה - icatibant as acetate 30 mg / 3 ml - icatibant - icatibant - symptomatic treatment of acute attacks of hereditary angioedima (hae) in adults (with c1 -esterase-inhibitor deficiency).